Daniella Beckman

Directeur/Membre du Conseil chez VOR BIOPHARMA INC.

Fortune : 3 M $ au 31/05/2026

47 ans

48 relations

Health Technology

Consumer Services

Finance

Profil

Daniella Beckman is Lead Independent Director at Vor Biopharma, Inc. since 2026 and Independent Director at Upstream Bio, Inc. since 2024.
Former roles include Independent Director at Blueprint Medicines Corp.
from 2021 to 2025, Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022, Independent Director at Translate Bio, Inc. from 2017 to 2021, Chief Financial Officer & PAO at Tango Therapeutics, Inc. from 2016 to 2026, Chief Financial Officer at BioNTech US, Inc. from 2015 to 2019, Chief Financial Officer at Beckman Consulting LLC from 2015 to 2019, CFO, Treasurer, Director & Vice President at Idenix Pharmaceuticals LLC from 2011 to 2014.
Education includes undergraduate studies at Boston University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
TANGO THERAPEUTICS, INC. 0,09 %	01/04/2026	131 689 ( 0,09 % )	3 M $	31/05/2026
UPSTREAM BIO, INC. -.--%	09/06/2026	0 ( -.--% )	- $	31/05/2026
VOR BIOPHARMA, INC. -.--%	11/06/2026	0 ( -.--% )	- $	31/05/2026

Postes actifs de Daniella Beckman

Sociétés	Poste	Début
VOR BIOPHARMA INC.	Directeur/Membre du Conseil	16/07/2020
UPSTREAM BIO, INC.	Directeur/Membre du Conseil	11/10/2024

Tous les postes actifs de Daniella Beckman

Anciens postes connus de Daniella Beckman

Sociétés	Poste	Fin
TANGO THERAPEUTICS, INC.	Directeur Financier/CFO	15/04/2026
BLUEPRINT MEDICINES CORPORATION	Directeur/Membre du Conseil	17/07/2025
501 ACQU	Directeur/Membre du Conseil	01/01/2022
TRANSLATE BIO, INC.	Directeur/Membre du Conseil	14/09/2021
NEON THERAPEUTICS, INC.	Directeur Financier/CFO	01/09/2019

Voir l'expérience en détail de Daniella Beckman

Formation de Daniella Beckman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Daniella Beckman

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	10
Idenix Pharmaceuticals LLC Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis	Health Technology
Translate Bio, Inc. Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Blueprint Medicines Corp. Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer	Health Technology
BioNTech US, Inc. BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer	Health Technology
Vor Biopharma, Inc. Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies	Health Technology
5:01 Acquisition Corp. 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
Beckman Consulting LLC Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Engages in the provision of consulting services	Commercial Services
Tango Therapeutics, Inc. Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines	Health Technology
Upstream Bio, Inc. Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases	Health Technology